Treating Fairly Research Award
The Treating Fairly Research Award from ASH funds research to address and reduce disparities in hematologic diseases through innovative scientific approaches.
Funder: American Society of Hematology
Due Dates: November 15, 2026 (full application deadline)
Funding Amounts: $200,000 total, distributed over 1–3 years at recipient's preference; max two awards per medical school.
Summary: Supports research addressing disparities and promoting equity in hematologic diseases, especially for investigators no longer eligible for ASH Scholar or AMFDP awards.
Key Information: Applicants must be ASH members, have completed terminal degree >13 years ago, and have ≤$500,000 in other resources.
Description
The Treating Fairly Research Award, offered by the American Society of Hematology (ASH), is designed to advance research that addresses disparities in health outcomes among patients with hematologic diseases. This award was established in response to reduced federal support for research on blood disorders disproportionately impacting specific populations. The program aims to foster equitable research opportunities and improve outcomes for all patients affected by hematologic conditions. It is part of ASH’s expanded commitment to supporting at-risk communities and researchers facing funding gaps.
